All articles by GlobalData Healthcare

ERS 2026: AstraZeneca’s IL-33 inhibitor tozorakimab reduces mucus plug burden in COPD

On September 7, at the 2026 European Respiratory Society (ERS) International Congress in Barcelona, AstraZeneca presented results from an integrated…
ESC 2026: oral and injectable GLP-1 comparisons under the spotlight

Treatments targeting glucagon-like peptide-1 (GLP‑1) receptors have come to play a pivotal part in the tools available when treating patients…
ESC 2026: Tirzepatide 5mg sustains cardiometabolic benefit with weight maintenance

On 28 August, at the European Society of Cardiology (ESC) Congress 2026 in Munich, Germany, a post-hoc analysis of the…
ESC 2026: Evidence supporting SGLT2 inhibitors and finerenone in heart failure grows

At the 2026 European Society of Cardiology (ESC) Scientific Sessions, hosted in Munich, Germany, researchers and care providers assembled to…
ESC 2026: Aficamten breaks new ground in nonobstructive HCM

This year at the European Society of Cardiology (ESC) Scientific Sessions, findings from the ACACIA-HCM trial explored the effect of…

ESC 2026: Evolocumab explores new frontiers in CV disease prevention

This year at the European Society of Cardiology (ESC) Scientific Sessions, new findings were presented from a pre-specified analysis of…
Myasthenia gravis market to reach $13.0bn across 7MM by 2034

The myasthenia gravis (MG) market across the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan) is…
CKD market expected to reach $10.9bn across the 7MM by 2035

The chronic kidney disease (CKD) market is poised to grow at a compound annual growth rate (CAGR) of 9.8% from…
Intismeran autogene a turning point for cancer vaccines

On 19 August, Moderna announced interim analysis data from the Phase III INTerpath-001 trial for intismeran autogene, a personalised mRNA…
Reformed pharmaceutical regulation across India’s drug landscape

India has recently introduced two significant reforms to its pharmaceutical regulatory framework that will impact the pricing of essential medicines…